Supporting Information

Table S1 shows the potential of single biomarkers of OS and AGMs and their combinations at early (10-20weeks) and mid-pregnancy (21-31 weeks gestation) for the prediction of all cases of preeclampsia (PE)
Table S2 shows the potential of single biomarkers of OS and AGMs, and their combined ratios at 10-20 weeks and 21-31 weeks gestation for the prediction of SHS-PWLD early-onset PE (EO-PE)
Table S3 demonstrates the potential of the single biomarkers of OS and AGMs, and their combination ratios at 10-20weeks and 21-31weeks gestation, for the prediction of SHS-PWLD late-onset PE (LO-PE)
Table S4 shows the potential of the single biomarkers of OS and AGMs, and their combinations at 10-20 weeks and 21-31 weeks gestation for the prediction of OHS-PWLD early-onset PE (EO-PE)
Table S5 demonstrate the potential of the single biomarkers of OS and AGMs, and their ratios in 10-20 weeks and 21-31 weeks gestation for the prediction of OHS-PWLD late-onset PE (LO-PE)